EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Eur J Cardiothorac Surg 2008;33:89-94. doi:10.1016/j.ejcts.2007.10.002
Copyright © 2008, European Association for Cardio-thoracic Surgery. Published by Elsevier. All rights reserved.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
William H. Warren
Anthony W. Kim
Michael J. Liptay
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Warren, W. H.
Right arrow Articles by Liptay, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Warren, W. H.
Right arrow Articles by Liptay, M. J.
Related Collections
Right arrow Pleura

Identification of clinical factors predicting Pleurx ® catheter removal in patients treated for malignant pleural effusion

William H. Warren*, Anthony W. Kim, Michael J. Liptay

Department of Cardiovascular-Thoracic Surgery, Rush University Medical Center, Chicago, IL 60612, USA

Received 31 May 2007; received in revised form 4 October 2007; accepted 8 October 2007.

* Corresponding author. Address: 1725 W. Harrison Street, Suite 774, Chicago, IL 60612, USA. Tel.: +1 312 738 3732; fax: +1 312 738 9763. (Email: wwarren{at}rush.edu).

Objective: The objective of the study was to review the clinical records of patients undergoing insertion of a Pleurx ® catheter in the management of malignant pleural effusions. In particular, clinical parameters were analyzed for their influence on catheter removeability. Methods: Between January 1998 and July 2006, 263 patients underwent insertion of 295 Pleurx ® catheters for malignant pleural effusion(s). Patients were allocated to one of four groups based upon the site of the primary tumor: group 1 (breast), group 2 (lung), group 3 (gynecologic), and group 4 (all others). A history of prior chest irradiation, cytologic analysis (positive or negative for malignant cells), and incidence of trapped lung were also studied to determine if, in addition to the primary site, these influenced the incidence of pleurodesis. Results: Overall, 58.6% of Pleurx ® catheters were removed prior to death. The incidence of spontaneous symphysis and catheter removal in groups 1 (69.6%) and 3 (72.5%) was significantly higher than in groups 2 and 4 (p < 0.001). In addition, absence of a history of chest wall irradiation, cytologic positivity and a trapped lung all influenced catheter removeability to a significant degree (p < 0.001). Conclusions: Pleurx ® catheters effectively relieve patients of dyspnea by evacuating the pleural space. Spontaneous pleural symphysis and catheter removal is more likely in patients with breast or gynecologic primary tumors, absence of chest wall irradiation, cytologic positivity, and complete re-expansion of the underlying lung.

Key Words: Pleural diseases • Malignant pleural effusion • Pleurx ® catheter • Trapped lung




This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
K. R. Flaherty
Clinical Year in Review IV: Pediatric Pulmonary and Critical Care, Cystic Fibrosis, Asthma, and Pleural Disease
Proceedings of the ATS, September 15, 2009; 6(6): 506 - 511.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.